DD-03B: Target-level analysis of ligand-protein dissociation pathways reveals ligand-specific exit pathways weakly coupled to binding affinity
summary
The gist
Understanding the kinetics of drug-protein interactions is paramount for drug design, yet the field lacks large-scale, dynamic data to move beyond static structural analysis.
In short
DD-03B is a massive database providing dynamic, all-atom simulations of ligand-protein dissociation trajectories. Researchers analyzed these trajectories to categorize complexes into three mechanistic types: pathway-dominant, open-pocket, and entropy-pocket systems. This resource allows training advanced AI models to predict drug binding kinetics and optimize drug design.
Key concepts
- DD-03B
- A large, scalable database containing dynamic simulations of ligand-protein dissociation trajectories for over 19,000 complexes. It provides experimental binding affinities (kd) but allows researchers to calculate dissociation rates (koff) through trajectory reweighting.
- Mechanistic Classification
- The process of grouping protein-ligand complexes into distinct types based on how the ligand leaves the pocket. These types—pathway-dominant, open-pocket, and entropy-pocket—dictate different strategies needed to accurately study the dissociation kinetics.
- Dissociation Rate Constants (koff)
- A kinetic parameter that measures how fast a drug molecule leaves its binding site on a protein. While often hard to measure directly, this paper calculates estimated koff values from dynamic simulations, which is crucial for understanding drug efficacy.
- AI Model Training Signal
- The rich data in DD-03B (trajectories, pathways) is used to train generative AI models. These models learn the complex relationship between a drug's structure and its kinetic behavior (koff/kd), enabling better prediction of how drugs will interact with proteins.
Terminology used across episodes
This episode discusses
- DD-03B: Target-level analysis of ligand-protein dissociation pathways reveals ligand-specific exit pathways weakly coupled to binding affinity · Paper Radio
- DiffPack: A Torsional Diffusion Model for Autoregressive Protein Side-Chain Packing
- A Novel 4-D Dataset Paradigm for Studying Complete Ligand-Protein Dissociation Dynamics
The paper
DD-03B: Target-level analysis of ligand-protein dissociation pathways reveals ligand-specific exit pathways weakly coupled to binding affinity · Read on arXiv
Maodong Li, Dechin Chen, Zhijun Pan, Zhe Wang, §Yi Isaac Yang
Institute of Systems and Physical Biology, Shenzhen Bay Laboratory
Transcript
Introduction to the show: ident: Physics. The day in general physics: instruments, methods and results across the field.
Kai: We're looking at the paper: "DD-03B: Target-level analysis of ligand-protein dissociation pathways reveals ligand-specific exit pathways weakly coupled to binding affinity".
Mira: Here's the gist of the paper. Understanding the kinetics of drug-protein interactions is paramount for drug design, yet the field lacks large-scale, dynamic data to move beyond static structural analysis.
Kai: Here, we present DD-03B, a massively scalable database providing dynamic, all-atom dissociation trajectories for a broad set of ligandprotein complexes.
Mira: For these systems—which possess experimental binding affinities (kd) but typically lack measured koff rates—we computed and assigned dissociation rate constants through trajectory reweighting.
Kai: Our analysis reveals that protein-ligand complexes can be categorised into three mechanistic types (pathway-dominant, open-pocket, and entropy-pocket systems), each requiring distinct strategies for accurate kinetic characterisation.
Paper summary: Mira: The paper "DD-03B: Target-level analysis of ligand-protein dissociation pathways reveals ligand-specific exit pathways weakly coupled to binding affinity" introduces DD-03B as this massively scalable database providing dynamic, all atom dissociation trajectories for a broad set of ligand protein complexes <ref:2604.06761#pg1,massively scalable database providing dynamic, all atom dissociation trajectories for a broad>.
Kai: They point out that understanding these kinetics is critical for drug design, but the field lacked large scale dynamic data to go beyond just static structural analysis.
Mira: They created DD-03B by applying a validated computational pipeline to nineteen thousand thirty-seven ligand protein complexes sourced from PDBbind plus version two thousand twenty R1, resulting in approximately zero point three billion simulation frames.
Lev: That expansion is substantial compared to their first phase database, DD-13M, which only covered hundreds of complexes and yielded around six hundred eighty complexes initially.
Kai: The key difference is that DD-03B lacks experimentally measured dissociation rate constants or koff rates; instead, they provide the experimental binding affinities like kd or IC50 for these systems <ref:2604.06761#pg1>.
Mira: This means the prediction challenge shifts; we’re not just matching structures anymore, we have to predict kinetics from thermodynamics.
Lev: The structural coverage is also much wider than before, with the maximum ligand size increasing to three hundred eighty atoms and the maximum protein size expanding to seventy-three thousand seven hundred seventeen atoms.
Kai: So they've scaled up the data significantly while keeping the all atom detail, which is crucial for detailed dynamics.
Mira: They also categorized these systems into five distinct types based on modelling success and trajectory acquisition, including Manual Setup and Single Pathway systems.
Lev: The simulation protocol used an automated high throughput molecular dynamics pipeline called SPONGE to generate these trajectories.
Conclusion: Kai: Looking at the title of this paper, "DD-03B: Target-level analysis of ligand-protein dissociation pathways reveals ligand-specific exit pathways weakly coupled to binding affinity," it suggests a very specific finding <ref:2604.06761#pg1>.
Mira: It suggests that the different ways a drug leaves a pocket—the exit pathways—are not just random; they are specifically tied to the drug itself, and these different ways aren't strongly linked to how tightly it binds, which is what we measure with kd or IC50.
Lev: So what this means for us is that when we train generative AI models to predict dissociation kinetics, we need to know which mechanistic type of system we are looking at before we even start predicting the rate constant.
Kai: The implication here is that the quality and scope of our training data directly determine the accuracy of the kinetic predictions those models can make for new drugs.
Mira: They’re building a foundation, DD-03B, which is intended to be continuously augmented with new trajectories to train next generation generative AI models to predict and optimize drug protein dissociation kinetics <ref:2604.06761#pg1>.
Lev: It sets up a framework where optimal sampling strategies will need to align with those three mechanistic perspectives they identified: explicit pathway, open pocket, and entropy pocket.
Kai: So the ultimate goal is using this massive resource, DD-03B, to develop and benchmark the next generation of predictive models for drug protein dissociation kinetics <ref:2604.06761#pg1>.
More episodes
- 2611.14082-Two atoms with strong light-induced dipolar interactions
- 2611.14040-Characterization of BNLs 20 and 30 micrometer thick LGADs for the Electron Ion Collider
- 2611.13399-Lift-element-based dynamic network of vortex gust-airfoil interactions
- 2611.13476-Hopfion Superlattices in 3D Twisted Moir'e Light Fields
- 2611.13642-Investigation of the timing performance of double-sided p-type 3D silicon sensors produced by CNM
- 2611.13830-SiPM optical readout of a PICOSEC Micromegas precise timing detector
- 2611.14152-Where are the shortest-path nodes in spatial networks?
- 2611.14219-Sub-Ice: semi-automated mapping of basal channels from ice shelf surface elevation data
- 2611.16341-SUMNO: Spatially Unrolled Multigrid Neural Operator for Fluid Flow Surrogates
- 2611.16090-Multi-UTE Myelin Fraction Mapping: Repeatability and Cross-Field-Strength Reproducibility at 1.5T and 3T